Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

NCT00530634 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
GENETIC: gene expression analysis
GENETIC: reverse transcriptase-polymerase chain reaction
OTHER: immunohistochemistry staining method
PROCEDURE: adjuvant therapy
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

City of Hope Medical Center

Collaborators

[object Object]